Targeting Non-Oncogene Addiction: Focus on Thyroid Cancer
Thyroid carcinoma (TC) is the most common malignancy of endocrine organs with an increasing incidence in industrialized countries. The majority of TC are characterized by a good prognosis, even though cases with aggressive forms not cured by standard therapies are also present. Moreover, target ther...
Main Authors: | Maria Chiara Anania, Tiziana Di Marco, Mara Mazzoni, Angela Greco |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/1/129 |
Similar Items
-
Is Immunotherapy Beneficial in Patients with Oncogene-Addicted Non-Small Cell Lung Cancers? A Narrative Review
by: David John McMahon, et al.
Published: (2024-01-01) -
Targeting Non-Oncogene Addiction for Cancer Therapy
by: Hae Ryung Chang, et al.
Published: (2021-01-01) -
Oncogene addiction and tumor mutational burden in non‐small‐cell lung cancer: Clinical significance and limitations
by: Elisabeth Smolle, et al.
Published: (2020-02-01) -
A view on EGFR-targeted therapies from the oncogene-addiction perspective
by: Rolando ePerez, et al.
Published: (2013-04-01) -
Role of Radiosurgery and Stereotactic Ablative Radiotherapy for Oligometastatic Non-Oncogene Addicted NSCLC
by: Serena Badellino, et al.
Published: (2022-03-01)